Driving Scientific Breakthroughs with Advanced Assay Development

On-Demand Recording

Thanks for your interest in our webinar exploring the cutting-edge capabilities of Quanterix's Accelerator Laboratory. As a leader in ultra-sensitive immunoassays, Quanterix offers a wide range of biomarker tests across neurology, inflammation, oncology, and infectious diseases. Learn how our services can streamline your research and clinical trials, driving your scientific breakthroughs.

In this webinar, Dr. Matthew C. Havrda, Associate Professor at Dartmouth’s Geisel School of Medicine, shared his research on neuroinflammation in Parkinson’s disease. His work, in collaboration with Quanterix and the Michael J. Fox Foundation, has led to the development of highly sensitive assays for inflammasome-related proteins. His insights show how these advanced assays can detect inflammasome activity in patient biofluids, aiding in patient stratification and treatment. Access the on-demand webinar to learn more.

If you see this, do not fill:

Fill in the form below.

First Name *
Last Name *
Email *
Company *
What type of organization is your company? *
Country *
State *
Therapeutic Area
To select multiple values, hold down the Shift or Control (PC) or Command (Mac) key.
I consent
By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.